Temporal variations in hematocrit values in patients with left ventricular dysfunction: Relationship with cause-specific mortality and morbidity and optimal monitoring - Further insights from SOLVD

Canadian Journal of Cardiology

Volumn 24, Issue 1, 2008, Pages 45-48

  de Denus, Simon ^a,b   Tardif, Jean Claude ^b   White, Michel ^b   Bourassa, Martial G ^b   Racine, Normand ^b   Levesque, Sylvie ^b   Ducharme, Anique ^b  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b MONTREAL HEART INSTITUTE   (Canada)

Author keywords

Anemia; Congestive heart failure; Morbidity; Mortality

Indexed keywords

ADULT; AGED; ANEMIA; ARTICLE; CARDIOVASCULAR DISEASE; FEMALE; FOLLOW UP; GENETIC VARIABILITY; GLOMERULUS FILTRATION RATE; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE ISCHEMIA; HEMATOCRIT; HOSPITALIZATION; HUMAN; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PATIENT MONITORING; PROGNOSIS; RETROSPECTIVE STUDY;

EID: 40749162331     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0828-282x(08)70547-6     Document Type: Article

References (30)

1. Androne AS, Katz SD, Lund L, et al. Hemodilution is common in patients with advanced heart failure. Circulation 2003;107:226-9.
2. Horwich TB, Fonarow GC, Hamilton MA, MacLellan WR, Borenstein J. Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure. J Am Coll Cardiol 2002;39:1780-6.
3. McClellan WM, Flanders WD, Langston RD, Jurkovitz C, Presley R. Anemia and renal insufficiency are independent risk factors for death among patients with congestive heart failure admitted to community hospitals: A population-based study. J Am Soc Nephrol 2002;13:1928-36.
4. Anand I, McMurray JJ, Whitmore J, et al. Anemia and its relationship to clinical outcome in heart failure. Circulation 2004; 110: 149-54.
5. Ezekowitz JA, McAlister FA, Armstrong PW. Anemia is common in heart failure and is associated with poor outcomes: Insights from a cohort of 12 065 patients with new-onset heart failure. Circulation 2003;107:223-5.
6. Mozaffarian D, Nye R, Levy WC. Anemia predicts mortality in severe heart failure: The prospective randomized amlodipine survival evaluation (PRAISE). J Am Coll Cardiol 2003;41:1933-9.
7. Al-Ahmad A, Rand WM, Manjunath G, et al. Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction. J Am Coll Cardiol 2001;38:955-62.
8. O'Meara E, Clayton T, McEntegart MB, et al; CHARM Committees and Investigators. Clinical correlates and consequences of anemia in a broad spectrum of patients with heart failure: Results of the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Program. Circulation 2006;113:986-94.
9. Ishani A, Weinhandl E, Zhao Z, et al. Angiotensin-converting enzyme inhibitor as a risk factor for the development of anemia, and the impact of incident anemia on mortality in patients with left ventricular dysfunction. J Am Coll Cardiol 2005;45:391-9.
10. Anand IS, Kuskowski MA, Rector TS, et al. Anemia and change in hemoglobin over time related to mortality and morbidity in patients with chronic heart failure: Results from Val-HeFT. Circulation 2005;112:1121-7.
11. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. The SOLVD Investigators. N Engl J Med 1992;327:685-91. (Erratum in 1992;327:1768).
12. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The SOLVD Investigators. N Engl J Med 1991;325:293,302.
13. Anavekar NS, McMurray JJ, Velazquez EJ, et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 2004;351:1285-95.
14. Poole-Wilson PA, Uretsky BE, Thygesen K, Cleland JG, Massie BM, Rydén L; Atlas Study Group. Assessment of treatment with lisinopril and survival. Mode of death in heart failure: Findings from the ATLAS trial. Heart 2003;89:42-8.
15. Sharma R, Francis DP, Pitt B, Poole-Wilson PA, Coats AJ, Anker SD. Haemoglobin predicts survival in patients with chronic heart failure: A substudy of the ELITE, II trial. Eur Heart J 2004;25:1021-28.
16. Dries DL, Exner DV, Domanski MJ, Greenberg B, Stevenson LW. The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction. J Am Coll Cardiol 2000;35:681-9.
17. Hillege HL, Girbes AR, de Kam PJ, et al. Renal function, neurohormonal activation, and survival in patients with chronic heart failure. Circulation 2000;102:203-10.
18. Cowie MR, Fox KF, Wood DA, et al. Hospitalization of patients with heart failure: A population-based study. Eur Heart J 2002;23:877-85.
19. Madsen BK, Hansen JF, Stokholm KH, Brøns J, Husum D, Mortensen LS. Chronic congestive heart failure. Description and survival of 190 consecutive patients with a diagnosis of chronic congestive heart failure based on clinical signs and symptoms. Eur Heart J 1994;15:303-10.
20. Amin MG, Tighiouart H, Weiner DE, et al. Hematocrit and left ventricular mass: The Framingham Heart study. J Am Coll Cardiol 2004;43:1276-82.
21. Silverberg D. Outcomes of anaemia management in renal insufficiency and cardiac disease. Nephrol Dial Transplant 2003;18(Suppl 2):ii7-12.
22. Grune T, Sommerburg O, Siems WG. Oxidative stress in anemia. Clin Nephrol 2000;53(1 Suppl):S18-22.
23. Cromie N, Lee C, Struthers AD. Anaemia in chronic heart failure: What is its frequency in the UK and its underlying causes? Heart 2002;87:377-8.
24. Smith GL, Vaccarino V, Kosiborod M, et al. Worsening renal function: What is a clinically meaningful change in creatinine during hospitalization with heart failure? J Card Fail 2003;9:13-25.
25. Gottlieb SS, Abraham W, Butler J, et al. The prognostic importance of different definitions of worsening renal function in congestive heart failure. J Card Fail 2002;8:136-41.
26. Means RT Jr. Advances in the anemia of chronic disease. Int J Hematol 1999;70:7-12.
27. Deswal A, Petersen NJ, Feldman AM, Young JB, White BG, Mann DL. Cytokines and cytokine receptors in advanced heart failure: An analysis of the cytokine database from the Vesnarinone trial (VEST). Circulation 2001;103:2055-9.
28. Silverberg DS, Wexler D, Iaina A. The importance of anemia and its correction in the management of severe congestive heart failure. Eur J Heart Fail 2002;4:681-6.
29. Ziesche S, Rector TS, Cohn JN. Interobserver discordance in the classification of mechanisms of death in studies of heart failure. J Card Fail 1995;1:127-32.
30. Silverberg DS, Wexler D, Blum M, et al. The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations. J Am Coll Cardiol 2000;35:1737-44.